Senseonics Holdings, Inc. cotiza a 8.92 USD y tiene una capitalización bursátil de $472M. En los últimos 12 meses ha facturado $49M con un margen de flujo de caja libre del -170.9%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are im…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.63 | $-0.71 | $-0.46 |
| Estimado | $-0.52 | $-0.62 | $-0.70 | $-0.43 |
| Sorpresa | — | -1.6% | -1.4% | -7.0% |
| Métrica | SENS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 44.7% | 57.0% | -12.3% |
| Operating Margin | -193.8% | -38.6% | -155.2% |
| Net Margin | -196.0% | -33.6% | -162.5% |
| FCF Margin | -170.9% | -13.9% | -157.0% |
| ROE | -113.2% | -40.4% | -72.8% |
| ROA | -54.7% | -32.0% | -22.7% |
| Current Ratio | 4.83 | 2.84 | +1.99 |
| Debt / Equity | 0.58 | 0.28 | +0.30 |